13-03-2023, 19:14

Spero Therapeutics Reschedules Fourth Quarter and Full Year

CAMBRIDGE, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset
Globe Newswire13-03-2023, 19:14
28-02-2023, 20:11

Spero Therapeutics to Present at Upcoming Investor

CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset
Globe Newswire28-02-2023, 20:11